
Xabclot 2.5mg Tablet
Marketer
Kasdap Healthcare Pvt Ltd
Salt Composition
Rivaroxaban (2.5mg)
Overview Xabclot 2.5mg Tablet
Anticoagulant medication, Xabclot 2.5mg tablets, works by thinning the blood to prevent and manage blood clots. This helps lower the risk of stroke and heart attack, preventing clot formation in vital areas such as the legs, lungs, brain, and heart. Frequently prescribed for patients with atrial fibrillation (irregular heartbeat), it also safeguards against clots following hip or knee replacements. Xabclot can be taken with or without food, consistently at the same time daily for optimal efficacy. Long-term use, potentially lifelong, may be necessary; discontinuing or altering dosage without physician consultation significantly increases the risk of stroke, heart attack, or thrombosis. Lifestyle modifications, including a healthy diet, regular exercise, weight management, and smoking cessation, further minimize clot risk. Increased bleeding (nosebleeds, bruising) is a common side effect; report any unusual symptoms to your doctor promptly. Contraindications include severe liver or kidney disease, active bleeding, and concurrent use of other anticoagulants. Breastfeeding is not recommended during treatment. Unlike some anticoagulants, routine PT-INR blood monitoring isn't needed with Xabclot.
Primary Ingredients of Xabclot 2.5mg Tablet
The provided text is "undefined," therefore no rewriting is possible.
Uses of Xabclot 2.5mg Tablet
Managing and averting blood clot formation
Major Benefits of Xabclot 2.5mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the 2.5mg Xabclot tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable; however, consistent timing is recommended for optimal results.
Common Side effects of Xabclot 2.5mg Tablet:
- Bleeding
How to use Xabclot 2.5mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the 2.5mg Xabclot tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, though consistent timing is recommended.
How Xabclot 2.5mg Tablet works:
Xabloclot 2.5mg tablets represent a new class of oral blood thinners. Their mechanism of action involves the inhibition of factor Xa, a key clotting agent, thus reducing the likelihood of blood clot development.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Xabclot 2.5mg Tablet with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Xabclot 2.5mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Xabclot 2.5mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving may be impaired by Xabclot 2.5mg Tablets, which can induce dizziness or fainting. These side effects could compromise your ability to operate a vehicle.
KidneyCAUTION
Individuals with impaired kidney function should exercise caution when taking Xabclot 2.5mg tablets, as dose modification may be necessary. Consult a physician for guidance. Xabclot 2.5mg tablets are contraindicated in patients exhibiting severe kidney disease.
LiverUNSAFE
The use of Xabclot 2.5mg tablets is likely inadvisable for individuals with hepatic impairment and should be omitted. Medical advice is recommended.
What if you forget to take Xabclot 2.5mg Tablet :
Should you forget to take your 2.5mg Xabclot tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Xabclot 2.5mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Morpholine-thiophene derivatives |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | Xa Inhibitors for Oral Administration |
